Example: Heart Attack

Search clinical trials for: Terazosin

Total 28 results

NCT04467931

Active, not recruiting

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Conditions: Hypertension; COVID
NCT04386317

Not yet recruiting

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Conditions: REM Sleep Behavior Disorder; Pre-motor Parkinson's Disease; Symptomatic Parkinson Disease
NCT04132583

Completed

Deflox Tablets Bioequivalence (BE) Trial

Conditions: Healthy
NCT03905811

Enrolling by invitation

Terazosin for Parkinson's Disease

Conditions: Parkinson Disease
NCT03653845

Recruiting

Adrenal Artery Ablation for Primary Aldosteronism

Conditions: Primary Aldosteronism; Hypertension
NCT03339258

Recruiting

A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

Conditions: Stress Disorders, Post-Traumatic
NCT03195673

Recruiting

Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

Conditions: Carotid Artery Stenosis
NCT02966717

Active, not recruiting

Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)

Conditions: Renal Insufficiency, Chronic; Nephrotic Syndrome
NCT02244255

Completed

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Conditions: Prostatic Hyperplasia
NCT02046395

Completed

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes; Hypertension
NCT01530243

Completed

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

Conditions: Disorder of Urinary Stent
NCT01508637

Unknown status

Diesel Exhaust and Vascular Function

Conditions: Cardiovascular Effects
NCT01435954

Completed

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

Conditions: Benign Prostatic Hyperplasia
NCT01390870

Completed

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

Conditions: Prostatic Hyperplasia
NCT01386983

Completed

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

Conditions: Prostatic Hyperplasia
NCT01366664

Completed

A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin

Conditions: Ejaculation
NCT01332435

Completed

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

Conditions: Prostatic Hyperplasia
NCT01332487

Completed

Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Conditions: Prostatic Hyperplasia
NCT01323998

Completed

Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan

Conditions: Prostatic Hyperplasia
NCT00700583

Completed

Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men

Conditions: Nocturia
NCT00693199

Completed

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

Conditions: Lower Urinary Tract Symptoms; Hypertension
NCT00687388

Withdrawn

The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia

Conditions: Benign Prostatic Hyperplasia
NCT00684489

Completed

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

Conditions: Hypertension
NCT00563485

Terminated

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Conditions: Prostatic Hyperplasia; Urinary Retention
NCT00449683

Completed

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin

Conditions: Hyperhidrosis
NCT00438113

Completed

Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

Conditions: Atrial Fibrillation
NCT00237510

Completed

Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating

Conditions: Antidepressant Induced Excessive Sweating
NCT00000620

Completed

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, Type 2; Diabetes Mellitus; Coronary Disease